Patients who are unlikely to comply with protocol requirements, e.g., uncooperative attitude, inability to return for the final visit

Patients who were previously enrolled in this study

Patients with a hypersensitivity to NovoMix® 30 or to any of the excipients

Women who are pregnant, breast feeding or have the intention of becoming pregnant within next 12 months

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes